Monocyte-eosinophil signaling axis promotes vaccine-mediated protection against SARS-CoV-2.
Saved in:
| Title: | Monocyte-eosinophil signaling axis promotes vaccine-mediated protection against SARS-CoV-2. |
|---|---|
| Authors: | Moore KM; Emory Vaccine Center, Emory National Primate Research Center, Emory UniversityAtlanta, GeorgiaUnited States of America.; Center for Childhood Infections and Vaccines of Children's Healthcare of Atlanta, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, United States of America., Foster SL; Emory Vaccine Center, Emory National Primate Research Center, Emory UniversityAtlanta, GeorgiaUnited States of America.; Center for Childhood Infections and Vaccines of Children's Healthcare of Atlanta, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, United States of America., Kar M; Emory Vaccine Center, Emory National Primate Research Center, Emory UniversityAtlanta, GeorgiaUnited States of America.; Center for Childhood Infections and Vaccines of Children's Healthcare of Atlanta, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, United States of America., Floyd KA; Emory Vaccine Center, Emory National Primate Research Center, Emory UniversityAtlanta, GeorgiaUnited States of America.; Center for Childhood Infections and Vaccines of Children's Healthcare of Atlanta, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, United States of America., Elrod EJ; Emory Vaccine Center, Emory National Primate Research Center, Emory UniversityAtlanta, GeorgiaUnited States of America.; Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America., Williams ME; Department of Microbiology and Immunology, Emory University; Atlanta, GeorgiaUnited States of America., Velden JV; Emory Vaccine Center, Emory National Primate Research Center, Emory UniversityAtlanta, GeorgiaUnited States of America.; Center for Childhood Infections and Vaccines of Children's Healthcare of Atlanta, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, United States of America., Ellis M; Emory Vaccine Center, Emory National Primate Research Center, Emory UniversityAtlanta, GeorgiaUnited States of America.; Center for Childhood Infections and Vaccines of Children's Healthcare of Atlanta, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, United States of America., Malik A; Emory Vaccine Center, Emory National Primate Research Center, Emory UniversityAtlanta, GeorgiaUnited States of America.; Center for Childhood Infections and Vaccines of Children's Healthcare of Atlanta, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, United States of America., Wali B; Emory Vaccine Center, Emory National Primate Research Center, Emory UniversityAtlanta, GeorgiaUnited States of America.; Center for Childhood Infections and Vaccines of Children's Healthcare of Atlanta, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, United States of America., Lapp S; Emory Vaccine Center, Emory National Primate Research Center, Emory UniversityAtlanta, GeorgiaUnited States of America., Metz A; Emory Vaccine Center, Emory National Primate Research Center, Emory UniversityAtlanta, GeorgiaUnited States of America., Bosinger SE; Emory Vaccine Center, Emory National Primate Research Center, Emory UniversityAtlanta, GeorgiaUnited States of America.; Emory NPRC Genomics Core Laboratory, Atlanta, GeorgiaUnited States of America., Menachery VD; Center for Childhood Infections and Vaccines of Children's Healthcare of Atlanta, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, United States of America., Seder RA; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Amara RR; Emory Vaccine Center, Emory National Primate Research Center, Emory UniversityAtlanta, GeorgiaUnited States of America.; Department of Microbiology and Immunology, Emory University; Atlanta, GeorgiaUnited States of America., Kohlmeier JE; Department of Microbiology and Immunology, Emory University; Atlanta, GeorgiaUnited States of America.; Emory Center of Excellence of Influenza Research and Response (CEIRR), Atlanta, Georgia, United States of America., Grakoui A; Emory Vaccine Center, Emory National Primate Research Center, Emory UniversityAtlanta, GeorgiaUnited States of America.; Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America., Suthar MS; Emory Vaccine Center, Emory National Primate Research Center, Emory UniversityAtlanta, GeorgiaUnited States of America.; Center for Childhood Infections and Vaccines of Children's Healthcare of Atlanta, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, United States of America.; Department of Microbiology and Immunology, Emory University; Atlanta, GeorgiaUnited States of America.; Emory Center of Excellence of Influenza Research and Response (CEIRR), Atlanta, Georgia, United States of America. |
| Source: | PLoS pathogens [PLoS Pathog] 2025 Dec 02; Vol. 21 (12), pp. e1013752. Date of Electronic Publication: 2025 Dec 02 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1553-7374 |
|---|---|
| DOI: | 10.1371/journal.ppat.1013752 |
